Export

Rituximab
Essential medicine status
General description
Rituximab is a monoclonal antibody used in treatment protocols for lymphomas and leukaemia, as well as various autoimmune inflammatory diseases.
INN
Rituximab
Medicine type
Biological agent
Wikipedia
DrugBank
Recommendations
Section
Targeted therapies
  • Parenteral > General injections > IV: 100 mg per 10 mL in 10 mL vial; 500 mg per 50 mL in 50 mL vial